Diagnostic Advances Distinguish Actionable Drivers of Early Progression in ER+ Breast Cancer
Ahmed Elkhanany, MD discusses unmet needs in patients with estrogen receptor–positive breast cancer who progress on frontline therapy, treatment considerations for these patients, and how FES PET imaging may benefit this population.
Source: onclive.com